Table 2 Genomic regions associated with unique CNVs identified in multiple patients

2 CNV gains

Gain

2

13,119,088

13,199,687

80.6

48

Gain

2

13,135,013

13,199,687

64.7

43

Gain

2

82,055,473

82,163,764

108.3

85

Gain

2

82,056,404

82,168,370

112.0

89

Gain

3

958,296

1,012,953

54.7

33

Gain

3

975,908

1,032,700

56.8

29

Gain

6

27,738,385

27,764,062

25.7

26

Gain

6

27,742,403

27,770,374

28.0

24

Gain

15

79,783,294

79,876,946

93.7

77

Gain

15

79,795,446

79,876,343

80.9

70

Gain

17

21,503,478

21,648,413

144.9

25

Gain

17

21,503,478

21,650,626

147.2

26

3 CNV gains

Gain

4

25,672,202

25,703,024

30.8

31

Gain

4

25,678,621

25,710,178

31.6

32

Gain

4

25,680,434

25,710,412

30.0

31

Gain

5

59,749,693

59,807,906

58.2

51

Gain

5

59,749,693

59,807,906

58.2

51

Gain

5

59,749,693

59,810,944

61.3

52

Gain

19

36,911,234

36,939,557

28.3

36

Gain

19

36,918,927

36,940,929

22.0

32

Gain

19

36,918,927

36,944,555

25.6

36

2 CNV losses

Loss

11

95,844,428

95,917,476

73.1

54

Loss

11

95,844,428

95,917,476

73.1

54

Loss

14

44,229,915

44,294,996

65.1

53

Loss

14

44,229,915

44,294,996

65.1

53

Loss

17

19,439,549

19,476,055

36.5

28

Loss

17

19,439,549

19,476,055

36.5

28

Loss

18

1,714,779

1,828,901

114.1

109

Loss

18

1,714,779

1,828,901

114.1

109

4 CNV losses

Loss

3

166,523,809

166,565,186

41.4

39

Loss

3

166,523,809

166,565,186

41.4

39

Loss

3

166,523,809

166,566,558

42.8

40

Loss

3

166,525,250

166,565,186

39.9

38

Loss

18

1,894,368

1,974,284

79.9

63

Loss

18

1,894,368

1,974,284

79.9

63

Loss

18

1,894,368

1,974,284

79.9

63

Loss

18

1,894,368

1,974,284

79.9

63

2 CNV gain and loss

Gain

4

160,917,340

161,068,954

151.6

119

Loss

4

160,983,513

161,011,918

28.4

29